{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:52:18Z","timestamp":1692838338873},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:00Z","timestamp":1603843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:00Z","timestamp":1603843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00292-020-00828-2","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T15:03:20Z","timestamp":1603897400000},"page":"124-128","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Knochenmarkfibrose bei prim\u00e4rer Myelofibrose in Abh\u00e4ngigkeit von myelodysplasie- und altersassoziierten Mutationen der H\u00e4matopoese"],"prefix":"10.1007","volume":"41","author":[{"given":"S.","family":"Bartels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Faisal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"B\u00fcsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Schlue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Hasemeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Schipper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Vogtmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Westphal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kreipe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,28]]},"reference":[{"key":"828_CR1","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber\u00a0DA, Orazi\u00a0A, Hasserjian\u00a0R, Thiele\u00a0J, Borowitz\u00a0MJ, Le Beau\u00a0MM, Bloomfield\u00a0CD, Cazzola\u00a0M, Vardiman\u00a0JW (2016) The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia. Blood 127:2391\u20132405","journal-title":"Blood"},{"key":"828_CR2","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/s41375-019-0668-5","volume":"34","author":"S Bartels","year":"2020","unstructured":"Bartels\u00a0S, Faisal\u00a0M, B\u00fcsche\u00a0G, Schlue\u00a0J, Hasemeier\u00a0B, Schipper\u00a0E, Vogtmann\u00a0J, Westphal\u00a0L, Lehmann\u00a0U, Kreipe\u00a0H (2020) Mutations associated with age-related clonal hematopoiesis in PMF patients with rapid progression to myelofibrosis. Leukemia 34:1364\u20131372","journal-title":"Leukemia"},{"key":"828_CR3","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/leu.2017.298","volume":"32","author":"S Bartels","year":"2018","unstructured":"Bartels\u00a0S, Faisal\u00a0M, B\u00fcsche\u00a0G, Schlue\u00a0J, Kreipe\u00a0H, Lehmann\u00a0U (2018) Fibrotic progression in polycythemia vera is associated with early concomitant driver-mutations besides JAK2. Leukemia 32:556\u2013558","journal-title":"Leukemia"},{"key":"828_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1309\/PTVGB3DXB8A8M7KD","volume":"119","author":"T Buhr","year":"2003","unstructured":"Buhr\u00a0T, Busche\u00a0G, Choritz\u00a0H, Langer\u00a0F, Kreipe\u00a0H (2003) Evolution of myelofibrosis in chronic idiopathic myelofibrosis as evidenced in sequential bone marrow biopsy specimens. Am J Clin Pathol 119:152\u2013158","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"828_CR5","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3324\/haematol.2011.047811","volume":"97","author":"T Buhr","year":"2012","unstructured":"Buhr\u00a0T, Hebeda\u00a0K, Kaloutsi\u00a0V, Porwit\u00a0A, Van der Walt\u00a0J, Kreipe\u00a0H (2012) European bone marrow working group trial on reproducibility of world health organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 97(3):360\u2013365. https:\/\/doi.org\/10.3324\/haematol.2011.047811","journal-title":"Haematologica"},{"issue":"3","key":"828_CR6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1136\/jcp.39.3.237","volume":"39","author":"R Burkhardt","year":"1986","unstructured":"Burkhardt\u00a0R, Bartl\u00a0R, J\u00e4ger\u00a0K, Frisch\u00a0B, Kettner\u00a0G, Mahl\u00a0G, Sund\u00a0M (1986) Working classification of chronic myeloproliferative disorders based on histological, haematological, and clinical findings. J\u00a0Clin Pathol 39(3):237\u2013252","journal-title":"J Clin Pathol"},{"key":"828_CR7","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1200\/JCO.2008.20.3174","volume":"27","author":"PJ Campbell","year":"2009","unstructured":"Campbell\u00a0PJ, Bareford\u00a0D, Erber\u00a0WN, Wilkins\u00a0BS, Wright\u00a0P, Buck\u00a0G, Wheatley\u00a0K, Harrison\u00a0CN, Green\u00a0AR (2009) Reticulin accumulation in essential thrombocythemia: prognostic significance and relationship to therapy. J\u00a0Clin Oncol 27:2991\u20132999","journal-title":"J Clin Oncol"},{"key":"828_CR8","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1038\/leu.2009.141","volume":"23","author":"N Carbuccia","year":"2009","unstructured":"Carbuccia\u00a0N, Murati\u00a0A, Trouplin\u00a0V et\u00a0al (2009) Mutations of ASXL1 gene in myeloproliferative neoplasms. Leukemia 23:2183\u20132186","journal-title":"Leukemia"},{"key":"828_CR9","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1182\/blood.V6.4.372.372","volume":"6","author":"W Dameshek","year":"1951","unstructured":"Dameshek\u00a0W (1951) Some speculations on the myeloproliferative syndromes. Blood 6:372\u2013375","journal-title":"Blood"},{"issue":"1","key":"828_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3109\/10428199609074357","volume":"22","author":"A Georgii","year":"1996","unstructured":"Georgii\u00a0A, Buhr\u00a0T, Buesche\u00a0G, Kreft\u00a0A, Choritz\u00a0H (1996) Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies. Leuk Lymphoma 22(1):15\u201329","journal-title":"Leuk Lymphoma"},{"key":"828_CR11","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1158\/1078-0432.CCR-17-3044","volume":"24","author":"CJ Gibson","year":"2018","unstructured":"Gibson\u00a0CJ, Steensma\u00a0DP (2018) New insights from studies of clonal hematopoiesis. Clin Cancer Res 24:4633\u20134642","journal-title":"Clin Cancer Res"},{"key":"828_CR12","doi-asserted-by":"publisher","first-page":"eaan4673","DOI":"10.1126\/science.aan4673","volume":"366","author":"S Jaiswal","year":"2019","unstructured":"Jaiswal\u00a0S, Ebert\u00a0BL (2019) Clonal hematopoiesis in human aging and disease. Science 366:eaan4673","journal-title":"Science"},{"key":"828_CR13","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/nature03546","volume":"434","author":"C James","year":"2005","unstructured":"James\u00a0C, Ugo\u00a0V, Le Cou\u00e9dic\u00a0JP, Staerk\u00a0J, Delhommeau\u00a0F, Lacout\u00a0C, Gar\u00e7on\u00a0L, Raslova\u00a0H, Berger\u00a0R, Bennaceur-Griscelli\u00a0A, Villeval\u00a0JL, Constantinescu\u00a0SN, Casadevall\u00a0N, Vainchenker\u00a0W (2005) A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434:1144\u20131148","journal-title":"Nature"},{"key":"828_CR14","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","volume":"369","author":"T Klampfl","year":"2013","unstructured":"Klampfl\u00a0T, Gisslinger\u00a0H, Harutyunyan\u00a0AS et\u00a0al (2013) Somatic mutations of calreticulin in myeloproliferative neoplasms. N\u00a0Engl J Med 369:2379\u20132390","journal-title":"N Engl J Med"},{"key":"828_CR15","first-page":"47","volume-title":"Knochenmark, Lymphatisches System, Milz, Thymus","author":"H Kreipe","year":"2018","unstructured":"Kreipe\u00a0H (2018) Neoplastische Bildungsst\u00f6rungen der H\u00e4matopoese mit erhaltener Ausreifung. In: M\u00fcller-Hermelink\u00a0HK, Kreipe\u00a0HH (Hrsg) Knochenmark, Lymphatisches System, Milz, Thymus. Springer, Berlin, S 47\u201388"},{"key":"828_CR16","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1055\/s-2006-942757","volume":"32","author":"HM Kvasnicka","year":"2006","unstructured":"Kvasnicka\u00a0HM, Thiele\u00a0J (2006) The impact of clinicopathological studies on staging and survival in essential thrombocythemia, chronic idiopathic myelofibrosis, and polycythemia rubra vera. Semin Thromb Hemost 32:362\u2013371","journal-title":"Semin Thromb Hemost"},{"key":"828_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/hon.2430","volume":"36","author":"R Latagliata","year":"2018","unstructured":"Latagliata\u00a0R et\u00a0al (2018) Comparison of JAK2V617F\u2010positive essential thrombocythaemia and early primary myelofibrosis: the impact of mutation burden and histology. Hematol Oncol 36:269\u2013275","journal-title":"Hematol Oncol"},{"key":"828_CR18","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1182\/blood-2012-11-467662","volume":"121","author":"U Lehmann","year":"2013","unstructured":"Lehmann\u00a0U, Bartels\u00a0S, Hasemeier\u00a0B, Geffers\u00a0R, Schlue\u00a0J, B\u00fcsche\u00a0G, Hussein\u00a0K, Kreipe\u00a0H (2013) SRSF2 mutation is present in the hypercellular and prefibrotic stage of primary myelofibrosis. Blood 121:4011\u20134012","journal-title":"Blood"},{"key":"828_CR19","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/leu.2016.130","volume":"30","author":"DC Link","year":"2016","unstructured":"Link\u00a0DC, Walter\u00a0MJ (2016) \u2018CHIP\u2019ping away at clonal hematopoiesis. Leukemia 30:1633\u20131635","journal-title":"Leukemia"},{"key":"828_CR20","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1056\/NEJMoa1412098","volume":"372","author":"CA Ortmann","year":"2015","unstructured":"Ortmann\u00a0CA, Kent\u00a0DG, Nangalia\u00a0J, Silber\u00a0Y, Wedge\u00a0DC, Grinfeld\u00a0J, Baxter\u00a0EJ, Massie\u00a0CE, Papaemmanuil\u00a0E, Menon\u00a0S, Godfrey\u00a0AL, Dimitropoulou\u00a0D, Guglielmelli\u00a0P, Bellosillo\u00a0B, Besses\u00a0C, D\u00f6hner\u00a0K, Harrison\u00a0CN, Vassiliou\u00a0GS, Vannucchi\u00a0A, Campbell\u00a0PJ, Green\u00a0AR (2015) Effect of mutation order on myeloproliferative neoplasms. N\u00a0Engl J Med 372:601\u2013612","journal-title":"N Engl J Med"},{"key":"828_CR21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/sj.leu.2400934","volume":"12","author":"WH Raskind","year":"1998","unstructured":"Raskind\u00a0WH, Steinmann\u00a0L, Najfeld\u00a0V (1998) Clonal development of myeloproliferative disorders: clues to hematopoietic differentiation and multistep pathogenesis of cancer. Leukemia 12:108\u2013116","journal-title":"Leukemia"},{"key":"828_CR22","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/leu.2013.286","volume":"28","author":"A Tefferi","year":"2014","unstructured":"Tefferi\u00a0A, Finke\u00a0CM, Lasho\u00a0TL et\u00a0al (2014) U2AF1 mutations in primary myelofibrosis are strongly associated with anemia and thrombocytopenia despite clustering with JAK2V617F and normal karyotype. Leukemia 28:431\u2013433","journal-title":"Leukemia"},{"key":"828_CR23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/ajh.24221","volume":"91","author":"A Tefferi","year":"2016","unstructured":"Tefferi\u00a0A (2016) Myeloproliferative neoplasms: a decade of discoveries and treatment advances. Am J Hematol 91:50\u201358. https:\/\/doi.org\/10.1002\/ajh.24221","journal-title":"Am J Hematol"},{"key":"828_CR24","first-page":"44","volume-title":"WHO classification of haematopoietic and lymphoid tissues","author":"J Thiele","year":"2008","unstructured":"Thiele\u00a0J, Kvasnicka\u00a0HM, Tefferi\u00a0A, Barosi\u00a0G, Orazi\u00a0A, Vardiman\u00a0JW (2008) Primary myelofibrosis. In: Swerdlow\u00a0SH, Campo\u00a0E, Lee Harris\u00a0N, Jaffe\u00a0ES, Pileri\u00a0SA, Stein\u00a0H, Thiele\u00a0J, Vardiman\u00a0JW (Hrsg) WHO classification of haematopoietic and lymphoid tissues. IARC Press, Lyon, S\u00a044\u201347"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-020-00828-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-020-00828-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-020-00828-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T07:10:48Z","timestamp":1611213048000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-020-00828-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,28]]},"references-count":24,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["828"],"URL":"https:\/\/doi.org\/10.1007\/s00292-020-00828-2","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,28]]},"assertion":[{"value":"28 October 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.\u00a0Bartels, M.\u00a0Faisal, G.\u00a0B\u00fcsche, J.\u00a0Schlue, B.\u00a0Hasemeier, E.\u00a0Schipper, J.\u00a0Vogtmann, L.\u00a0Westphal, U.\u00a0Lehmann und H.\u00a0Kreipe geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Die vorgelegte Studie erfolgte nach Pr\u00fcfung und Genehmigung durch das Ethik-Kommitee der Medizinischen Hochschule Hannover und schloss keine Tierversuche ein.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"The supplement containing this article is not sponsored by industry.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}